-
Evolving World of Pharma: Supply Chain Disruption Going Viral
Sarah Harding
April 02, 2020
It has been estimated that as much as 80% of APIs used by pharma manufacturers in the US originate from China or India.
-
Viroclinics and DDL Join Forces
contractpharma
March 04, 2020
Two virology testing laboratories integrate to form new group serving the global biopharmaceutical industry.
-
Alternative viral delivery of gene therapy developed
europeanpharmaceuticalreview
September 10, 2019
New nanocapsules are a promising platform for many types of gene therapies due to their small size and superior stability.
-
Compliance With Meds Falters With Age in Youth Born With HIV
drugs
August 05, 2019
For adolescents with perinatally acquired HIV, the prevalence of medication nonadherence and unsuppressed viral load increases with age...
-
Ampersand to Acquire Vibalogics
contractpharma
May 31, 2019
CDMO will expand capabilities to meet growing demand for development and manufacturing of complex viral products.
-
Personalizing viral phages to fight resistant infections
fiercebiotech
May 10, 2019
The Howard Hughes Medical Institute and the University of Pittsburgh started a program called SEA-PHAGES in the 1990s that offered college students an opportunity to hunt for bacteria-killing viruses known as bacteriophages.
-
Antibiotic use increases risk of severe viral disease in mice
europeanpharmaceuticalreview
April 28, 2019
Killing gut bacteria with drugs weakens immune response…
-
Flu’s response to Xofluza explored
europeanpharmaceuticalreview
April 22, 2019
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge…
-
Radiance could be the key to faster viral detection
europeanpharmaceuticalreview
April 18, 2019
Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection…
-
CEVEC Expands AAV Production Platform
contractpharma
April 17, 2019
Secures funding to expand commercialization of CAP GT-based stable adeno-associated viral (AAV) vector production platform...